THE HOME OF PEER-TO-PEER
VIRTUAL SUPPORT GROUPS
Virtual Support Groups
AnCan was the first to innovate virtual, real time, video chat support groups in multiple conditions moderated by patients for patients.
Patient Navigation
AnCan offers individual patient navigation for treatment at all stages.
Exercise & Wellness
In partnership with MedaFit, we connect patients and their medical team to exercise programs through highly qualified exercise counselors.
National Advocacy
Answer Cancer is active on a national stage working to improve patient care.
About Us
AnCan is about people helping people, peer-to-peer ….. we are people living with various conditions and situations, who help others faced with similar issues. We do this collectively and individually by providing answers, support and navigation to empower people living with serious and chronic conditions to address their situations.
Instructions for Joining a Group
Scroll Down to "HOW TO JOIN" on this page for link and other instructions.
Click HERE to sign up for email reminders for this, and other groups we offer.
NEW: Join the AnCan Patient Forum to connect with other group members
Recent News
AnCan is more than prostate cancer – two articles for our other groups!
Admittedly AnCan has a bias to prostate cancer .... after all that's where we proved our concept - and why one virtual meeting a month has blossomed into 22! Articles cross our transom that pertain our other groups, and here are a couple that caught our eye in the...
Physician conflict may not always best serve the patient
Editor's Note: Some of our AnCan prostate cancer community have alrady seen this message, but we felt it was important enough to broad- rather than just narrowcast! AnCan has recently noted a couple of examples where involving more rather than fewer doctors can be...
CancerCare’s April-May Workshops
Leading Experts Discuss Important Cancer Topics Make sure you've signed up for our upcoming Connect Education Workshops! These free workshops provide the latest cancer information straight from leading experts, via phone or online. At the end of the workshop, you'll...
Upcoming Groups & EVENTS
*Days may change due to holidays
AnCan Foundation is a volunteer organization with a handful of paid staff. All our events are free, and all groups are free and drop-in. AnCan has limited capacity to provide one-one-one navigation. If we do, it is provided by volunteer peer mentors. Out of respect for their time, we request a donation in an amount you see fit. No one is turned away.
Solo Arts Heal
Active Surveillance Prostate Cancer
High Risk/Recurrent/Advanced Prostate Cancer Men and Caregivers Video Chat Virtual Support
Visual Snow Syndrome
Cancer Caregivers
Veterans
Active Surveillance Prostate Cancer
Men ‘Speaking Freely’
Looking for a video chat group?
If you’d like to see all of our current groups, click here.
The Faces of AnCan
Meet the wonderful people that make AnCan possible.
AnCan Fun Facts
24
Monthly Groups
20
Moderators
9
Conditions Served
Our Blog
Keep up on all of the latest AnCan news, group recaps, and events in our blog!
Solo Arts Heal with Claire Gaskin
AnCan and The Marsh (well renown, long-established theater company with a large following in the Bay Area and venues in San Francisco and Oakland) collaborate every 4th Wednesday of the month for Solo Arts Heal!
We started 2023 off with guest, Claire Gaskin!
Claire is a poet who has published five volumes of poetry since 1998, most recently Ismene’s Survivable Resistance in 2021. (If you remember the Greek tragedy of Antigone, Ismene is the sister who was left behind to remember the trauma of it all). Claire has been a creative writing teacher and mentor for more than 30 years. She teaches not only at the university level but also dedicates herself to helping students at community centers to use writing to process trauma.
Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023
Hi-Risk/Recurrent/Advanced PCa Video Chat – A spectrum of therapies plus unanswered questions on imaging
FDA Approves Briumvi (Ublituximab) for Relapsing Multiple Sclerosis
FDA Approves Briumvi (Ublituximab) for Relapsing Multiple Sclerosis